Literature DB >> 9619300

Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: interaction in the recognition of endothelin-1 between ETA and ETB receptors.

A Himeno1, K Shigematsu, T Taguchi, M Niwa.   

Abstract

1. 125I-Endothelin (ET)-1 binding to the rat anterior pituitary gland was saturable and single, with a Kd of 71 pM and a Bmax of 120 fmol/mg. 2. When 1.0 microM BQ-123 (ETA antagonist) was added to the incubation buffer, the binding parameters were 8.3 pM and 8.0 fmol/mg, whereas 10 nM sarafotoxin S6c (ETB agonist) exerted little change in these binding parameters (Kd, 72 pM; Bmax, 110 fmol/mg). 3. ETB receptor-related compounds such as sarafotoxin S6c, ET-3, IRL1620, and BQ-788 competitively inhibited 125I-ET-1 binding, only when 1.0 microM BQ-123 was present in the incubation buffer. 4. Thus, the ETB receptor is capable of binding ET-1 when the ETA receptor is being occupied by BQ-123. A collaboration mechanism between the ETA and the ETB receptor may function in the recognition of ET-1, a typical "bivalent" ligand.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9619300     DOI: 10.1023/a:1022557717481

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  10 in total

1.  Coexpression studies with endothelin receptor subtypes indicate the existence of intracellular cross-talk between ET(A) and ET(B) receptors.

Authors:  S Ozaki; K Ohwaki; M Ihara; K Ishikawa; M Yano
Journal:  J Biochem       Date:  1997-03       Impact factor: 3.387

Review 2.  Selective naltrexone-derived opioid receptor antagonists.

Authors:  A E Takemori; P S Portoghese
Journal:  Annu Rev Pharmacol Toxicol       Date:  1992       Impact factor: 13.820

3.  Cloning and expression of a cDNA encoding an endothelin receptor.

Authors:  H Arai; S Hori; I Aramori; H Ohkubo; S Nakanishi
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

4.  Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor.

Authors:  T Sakurai; M Yanagisawa; Y Takuwa; H Miyazaki; S Kimura; K Goto; T Masaki
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

5.  The endothelin ETA receptor exists in the caudal solitary tract nucleus of the rat brain.

Authors:  S Shibata; M Niwa; A Himeno; N G Gana; K Shigematsu; M Matsumoto; K Yamashita; K Sumikawa; K Taniyama
Journal:  Cell Mol Neurobiol       Date:  1997-02       Impact factor: 5.046

6.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

7.  Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi.

Authors:  T Fukuroda; S Ozaki; M Ihara; K Ishikawa; M Yano; T Miyauchi; S Ishikawa; M Onizuka; K Goto; M Nishikibe
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

8.  Distinct subdomains of human endothelin receptors determine their selectivity to endothelinA-selective antagonist and endothelinB-selective agonists.

Authors:  A Sakamoto; M Yanagisawa; T Sawamura; T Enoki; T Ohtani; T Sakurai; K Nakao; T Toyo-oka; T Masaki
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

Review 9.  The current endothelin receptor classification: time for reconsideration?

Authors:  W A Bax; P R Saxena
Journal:  Trends Pharmacol Sci       Date:  1994-10       Impact factor: 14.819

10.  Characterization of endothelin receptors in the anterior pituitary gland.

Authors:  B Kanyicska; M E Freeman
Journal:  Am J Physiol       Date:  1993-10
  10 in total
  1 in total

Review 1.  The cardiovascular physiology and pharmacology of endothelin-1.

Authors:  Eric Thorin; Martine Clozel
Journal:  Adv Pharmacol       Date:  2010
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.